Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chiesi Farmaceutici S.P.A. Encouraged to Contact Lawyers at Deans & Lyons

DALLAS, Oct. 18, 2013 /PRNewswire/ -- Securities lawyers at Deans & Lyons announced a class action against the board of Cornerstone Therapeutics Inc. (NASDAQ: CRTX) in connection with a buyout for $9.50 per share. Concerned CRTX investors should contact attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies.

"Chiesi Farmaceutici has been a controlling shareholder since 2009 and currently owns 58% of Cornerstone stock. Yahoo! Finance has valued Cornerstone above the deal price consistently for the past month," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the Cornerstone Therapeutics Inc. shareholders receive the highest price reasonably available for their stock." 

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide.  CRTX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
hlindley@deanslyons.com
www.deanslyons.com

SOURCE Deans & Lyons, LLP